PET/CT findings in gastric cancer: Potential advantages and current limitations

Saadet Atay-Rosenthal, Richard L. Wahl, Elliot K. Fishman

Research output: Contribution to journalReview article

Abstract

18F-fluorodeoxyglucose ( 18F-FDG) as a substrate for tumors with high glucose metabolism has been the most commonly used 18F-FDG-PET radiopharmaceutical in oncologic imaging. However, the usefulness of 18F-FDG-PET in gastric cancer has not yet been fully established. The intent of this review is to help to better understand the impact of 18F-FDG-PET on the imaging of gastric cancer, to offer a greater understanding of how gastric malignancies may present and be recognized on 18F-FDG-PET and to assess the complementary value of PET/CT in gastric cancer staging.

Original languageEnglish (US)
Pages (from-to)241-250
Number of pages10
JournalImaging in Medicine
Volume4
Issue number2
DOIs
StatePublished - Apr 1 2012

Keywords

  • F-FDG-PET
  • F-fluorodeoxyglucose
  • PET/CT
  • TNM staging
  • gastric cancer staging
  • gastric carcinoma

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'PET/CT findings in gastric cancer: Potential advantages and current limitations'. Together they form a unique fingerprint.

  • Cite this